AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9119883 — intervention group
Group type: EXPERIMENTAL
Intervention: CM101 (7.5 micrograms/kg, 15 micrograms/kg, 24.75 micrograms/kg, 37.5 micrograms/kg) administered via i.v. infusion over 15 min, one cycle of therapy consisting of three treatments during 1 week.
Number of subjects: 15
Study 8353062 — intervention group
Group type: EXPERIMENTAL
Intervention: text-plus-picture condition
Number of subjects: 59
Study 8353062 — intervention group
Group type: COMPARATOR
Intervention: text-plus-text condition
Number of subjects: 59
Study 2956983 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymoxamine (0.15 mg kg‐1 loading dose followed by 0.15 mg kg‐1 h‐1)
Number of subjects: 5
Study 2956983 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine (1.5 mg loading dose followed by 1.5 mg h‐1)
Number of subjects: 5
Study 2956983 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 5
Study 31608416 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month aerobic exercise programme (14 males, 11 females)
Number of subjects: 50
Study 31608416 — intervention group
Group type: COMPARATOR
Intervention: Balance and flexibility programme (15 males, 10 females)
Number of subjects: 50
Study 31608416 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month aerobic exercise programme
Number of subjects: 50
Study 29500209 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day treatment arm (7 days of cefuroxime/cefuroxime axetil followed by 3 days of blinded placebo)
Number of subjects: 221
Study 29500209 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day treatment arm (7 days of cefuroxime/cefuroxime axetil followed by 3 days of blinded cefuroxime axetil)
Number of subjects: 221
Study 27506742 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (dietary management and increased physical activity)
Number of subjects: 87
Study 27506742 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 87
Study 24885793 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh embryo transfer on day 3 after oocyte retrieval
Number of subjects: 1180
Study 24885793 — intervention group
Group type: COMPARATOR
Intervention: Elective embryo cryopreservation followed by frozen-thawed embryo transfer
Number of subjects: 1180
Study 22694906 — intervention group
Group type: EXPERIMENTAL
Intervention: adjunctive group interpersonal psychotherapy (IPT) for MDD
Number of subjects: 38
Study 22694906 — intervention group
Group type: COMPARATOR
Intervention: attention‐matched control condition
Number of subjects: 38
Study 20353624 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine 1.5 mg once a day, increasing to 1.5 mg twice a day after seven days
Number of subjects: 15
Study 20353624 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical tablets)
Number of subjects: 15
Study 20353624 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 15
Study 20353624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 18550954 — intervention group
Group type: EXPERIMENTAL
Intervention: Squat group (Sq) - 3 series of 3 squat repetitions at 90% of individual maximum value and a sprint before agility circuit
Number of subjects: 26
Study 18550954 — intervention group
Group type: COMPARATOR
Intervention: Reference group (Re) - individual technical work only
Number of subjects: 26
Study 18550954 — intervention group
Group type: COMPARATOR
Intervention: Coordination group (Co) - circuit designed to promote agility, coordination, and balance control with some technical work
Number of subjects: 26
Study 16597218 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 93
Study 14643271 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic periodontitis (CP) in AMI group
Number of subjects: 160
Study 14643271 — intervention group
Group type: COMPARATOR
Intervention: Chronic periodontitis (CP) in non-AMI group
Number of subjects: 160
Study 14643271 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone loss exceeding 4mm at >/=50% of teeth in AMI group
Number of subjects: 160
Study 14643271 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone loss exceeding 4mm at >/=50% of teeth in non-smokers
Number of subjects: 160
Study 10981486 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone followed by prednisolone (group B)
Number of subjects: 26
Study 10981486 — intervention group
Group type: COMPARATOR
Intervention: None (group A and group C)
Number of subjects: 26
Study 9208532 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of TCM and chemotherapy (Group A)
Number of subjects: 102
Study 9208532 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (Group B)
Number of subjects: 102
Study 1579962 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodilution therapy (venesection/dextran 40)
Number of subjects: 102
Study 1579962 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study 6717888 — intervention group
Group type: EXPERIMENTAL
Intervention: Lonidamine plus adriamycin
Number of subjects: 25
Study 6717888 — intervention group
Group type: COMPARATOR
Intervention: Adriamycin alone
Number of subjects: 25
Study 29715705 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifecta valve
Number of subjects: 100
Study 29715705 — intervention group
Group type: COMPARATOR
Intervention: Perimount Magna Ease valve
Number of subjects: 100
Study 29196962 — intervention group
Group type: EXPERIMENTAL
Intervention: Moral Injury Symptom Scale-Military Version (MISS-M)
Number of subjects: 427
Study 27466699 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin analogs (SAs)
Number of subjects: 18
Study 27466699 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 18
Study 24804185 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Achilles millefolium 5% gel (twice daily for four weeks) along with weekly intralesional Glucantime injections
Number of subjects: 60
Study 24804185 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice daily for four weeks) along with weekly intralesional Glucantime injections
Number of subjects: 60
Study 24804185 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Achilles millefolium 5% gel
Number of subjects: 60
Study 24804185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 22161686 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH(1-84) 100 µg/day subcutaneously
Number of subjects: 62
Study 22161686 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 19949852 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile feedback system using a sensor mat to detect problematic postures.
Number of subjects: 0
Study 18984456 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS) ON
Number of subjects: 11
Study 18984456 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS) OFF
Number of subjects: 11
Study 18984456 — intervention group
Group type: COMPARATOR
Intervention: CSX patients compared to healthy controls
Number of subjects: 11
Study 18984456 — intervention group
Group type: EXPERIMENTAL
Intervention: SCS ON vs SCS OFF
Number of subjects: 11
Study 18984456 — intervention group
Group type: EXPERIMENTAL
Intervention: SCS OFF phase
Number of subjects: 11
Study 15891150 — intervention group
Group type: EXPERIMENTAL
Intervention: O(2)-O(3) infiltration
Number of subjects: 306
Study 15891150 — intervention group
Group type: COMPARATOR
Intervention: Steroid injection
Number of subjects: 306
Study 12371526 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP 500 microg bid via MDI with HFA-134a
Number of subjects: 116
Study 12371526 — intervention group
Group type: COMPARATOR
Intervention: CFC propellant (Becotide)
Number of subjects: 116
Study 12371526 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BDP HFA and CFC)
Number of subjects: 116
Study 10618940 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine bolus of 25 micrograms and infusion of 19 micrograms h‐1 added to 0.03% bupivacaine
Number of subjects: 45
Study 10618940 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine bolus of 50 micrograms and infusion of 37 micrograms h‐1 added to 0.03% bupivacaine
Number of subjects: 45
Study 10618940 — intervention group
Group type: COMPARATOR
Intervention: 0.03% bupivacaine alone
Number of subjects: 45
Study 10618940 — intervention group
Group type: EXPERIMENTAL
Intervention: Both clonidine groups
Number of subjects: 45
Study 8554488 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole echocardiography (DET)
Number of subjects: 78
Study 8554488 — intervention group
Group type: COMPARATOR
Intervention: Exercise stress test
Number of subjects: 78
Study 8554488 — intervention group
Group type: COMPARATOR
Intervention: Tc99MIBI-dipyridamole planar myocardial scintigraphy
Number of subjects: 78
Study 1767060 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/mq of i.v. cisplatin administered 30-60 minutes before each radiation therapy session (Group A)
Number of subjects: 96
Study 1767060 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 96
Study 6754242 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofluorophosphate dentifrice
Number of subjects: 2008
Study 6754242 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride dentifrice
Number of subjects: 2008
Study 6754242 — intervention group
Group type: COMPARATOR
Intervention: Control group (toothpaste without fluoride)
Number of subjects: 2008
Study 29725851 — intervention group
Group type: EXPERIMENTAL
Intervention: LPF+ADM
Number of subjects: 22
Study 29725851 — intervention group
Group type: COMPARATOR
Intervention: LPF
Number of subjects: 22
Study 29787288 — intervention group
Group type: EXPERIMENTAL
Intervention: Zephyr Endobronchial Valve (EBV)
Number of subjects: 190
Study 29787288 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 190
Study 27380343 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care-led meetings with informational brochure
Number of subjects: 365
Study 27380343 — intervention group
Group type: COMPARATOR
Intervention: Routine family meetings with informational brochure
Number of subjects: 365
Study 24965834 — intervention group
Group type: EXPERIMENTAL
Intervention: Human-powered nebuliser with 2.5 mg dose of salbutamol
Number of subjects: 110
Study 24965834 — intervention group
Group type: COMPARATOR
Intervention: Electric nebuliser with 2.5 mg dose of salbutamol
Number of subjects: 110
Study 22240597 — intervention group
Group type: EXPERIMENTAL
Intervention: voglibose (0.9 mg/day)
Number of subjects: 302
Study 22240597 — intervention group
Group type: EXPERIMENTAL
Intervention: nateglinide (180 mg/day)
Number of subjects: 302
Study 22240597 — intervention group
Group type: COMPARATOR
Intervention: lifestyle intervention
Number of subjects: 302
Study 22240597 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved glycemic status
Number of subjects: 302
Study 20061334 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide (30 mg/2 weeks i.m. increasing to 30 mg/week i.m. at week 8 if mean GH >2.5 microg/l)
Number of subjects: 108
Study 20061334 — intervention group
Group type: COMPARATOR
Intervention: Transsphenoidal surgery
Number of subjects: 108
Study 17028419 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone (25 mg o.d. for 4 days)
Number of subjects: 9
Study 17028419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 14706319 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrel‐Dubousset instrumentation system
Number of subjects: 82
Study 14706319 — intervention group
Group type: COMPARATOR
Intervention: Colorado instrumentation system
Number of subjects: 82
Study 14706319 — intervention group
Group type: EXPERIMENTAL
Intervention: Both instrumentation systems
Number of subjects: 82
Study 11748092 — intervention group
Group type: EXPERIMENTAL
Intervention: γ-irradiation (192Ir) for native coronary artery ISR
Number of subjects: 78
Study 11748092 — intervention group
Group type: EXPERIMENTAL
Intervention: γ-irradiation (192Ir) for saphenous vein graft ISR
Number of subjects: 78
Study 11748092 — intervention group
Group type: COMPARATOR
Intervention: Comparison of native artery ISR and SVG ISR
Number of subjects: 78
Study 9554247 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclofem
Number of subjects: 100
Study 9554247 — intervention group
Group type: COMPARATOR
Intervention: DMPA
Number of subjects: 100
Study 7803596 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white morning light (tau 2500 lux)
Number of subjects: 31
Study 7803596 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white evening light (tau 2500 lux)
Number of subjects: 31
Study 7803596 — intervention group
Group type: EXPERIMENTAL
Intervention: Dim red evening light (< 10 lux)
Number of subjects: 31
Study 7803596 — intervention group
Group type: COMPARATOR
Intervention: Control (NC)
Number of subjects: 31
Study 3152402 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Wave Doppler (CW)
Number of subjects: 14
Study 3152402 — intervention group
Group type: COMPARATOR
Intervention: Pulsed Doppler (PD)
Number of subjects: 14
Study 31623766 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1900
Study 31623766 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1900
Study 28686474 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aripiprazole (5 mg/day if <50 kg; 10 mg/day if ≥50 kg)
Number of subjects: 133
Study 28686474 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aripiprazole (10 mg/day if <50 kg; 20 mg/day if ≥50 kg)
Number of subjects: 133
Study 28686474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 25220550 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant 80 mg + Dexamethasone 8 mg
Number of subjects: 60
Study 25220550 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 8 mg
Number of subjects: 60
Study 25220550 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant + Dexamethasone
Number of subjects: 60
Study 25220550 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 60
Study 23591120 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent energy restriction (IECR)
Number of subjects: 115
Study 23591120 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent energy and carbohydrate restriction with ad libitum protein and fat (IECR+PF)
Number of subjects: 115
Study 23591120 — intervention group
Group type: COMPARATOR
Intervention: Daily energy restriction (DER)
Number of subjects: 115
Study 21281406 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole (500 mg single dose)
Number of subjects: 1042
Study 21281406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1042
Study 21281406 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole
Number of subjects: 1042
Study 21281406 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensities of hookworm and Trichuris infections
Number of subjects: 1042
Study 21281406 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate/heavy Trichuris infection
Number of subjects: 1042
Study 21281406 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate/heavy hookworm co-infection
Number of subjects: 1042
Study 19930566 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% hypertonic saline in 6% dextran 70, single dose of 250 ml
Number of subjects: 0
Study 19930566 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study 15010401 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release codeine (CC)
Number of subjects: 84
Study 15010401 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen plus codeine (A/C; 300 mg/30 mg)
Number of subjects: 84
Study 10358130 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate (CHO) diet (80% of energy as CHO)
Number of subjects: 6
Study 10358130 — intervention group
Group type: COMPARATOR
Intervention: Low carbohydrate (CHO) diet (10% of energy as CHO)
Number of subjects: 6
Study 8586009 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 21
Study 8586009 — intervention group
Group type: COMPARATOR
Intervention: Nitrendipine
Number of subjects: 21
Study 1967533 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg temazepam
Number of subjects: 12
Study 1967533 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg temazepam
Number of subjects: 12
Study 1967533 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 7426335 — intervention group
Group type: EXPERIMENTAL
Intervention: Early diagnostic splenectomy
Number of subjects: 67
Study 7426335 — intervention group
Group type: COMPARATOR
Intervention: Total nodal irradiation (control)
Number of subjects: 67
Study 30375070 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (Ado) 18-36 mg
Number of subjects: 40
Study 30375070 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol (Iso) 3-20 µg/min
Number of subjects: 40
Study 30375070 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol (Iso)
Number of subjects: 40
Study 30375070 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (Ado)
Number of subjects: 40
Study 28626249 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of free delivery policy
Number of subjects: 360
Study 28626249 — intervention group
Group type: EXPERIMENTAL
Intervention: Education level
Number of subjects: 360
Study 28626249 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of stay
Number of subjects: 360
Study 28626249 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving transportation support
Number of subjects: 360
Study 28626249 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with quality of services
Number of subjects: 360
Study 28626249 — intervention group
Group type: EXPERIMENTAL
Intervention: Accessibility to health facilities
Number of subjects: 360
Study 27128565 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium salt substitute (65% NaCl, 25% KCl, 10% MgSO4)
Number of subjects: 200
Study 27128565 — intervention group
Group type: COMPARATOR
Intervention: Normal salt (100% sodium chloride)
Number of subjects: 200
Study 24421329 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomalidomide + low-dose dexamethasone (POM+LoDEX)
Number of subjects: 221
Study 24421329 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide (POM)
Number of subjects: 221
Study 22766815 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun cream with jellyfish sting inhibitor
Number of subjects: 38
Study 22766815 — intervention group
Group type: COMPARATOR
Intervention: Ordinary sun cream
Number of subjects: 38
Study 22766815 — intervention group
Group type: COMPARATOR
Intervention: No cream
Number of subjects: 38
Study 19541578 — intervention group
Group type: EXPERIMENTAL
Intervention: CNI at 25% of the initial dose + 1000 mg MMF b.i.d. (group 2; n = 13)
Number of subjects: 21
Study 19541578 — intervention group
Group type: COMPARATOR
Intervention: CNI-free MMF/prednisone-based treatment (group 1; n = 8)
Number of subjects: 21
Study 17251060 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte-reduced red cell concentrates (LR-RC)
Number of subjects: 100
Study 17251060 — intervention group
Group type: COMPARATOR
Intervention: Non-leukocyte-reduced red cell concentrates (non-LR-RC)
Number of subjects: 100
Study 15923284 — intervention group
Group type: EXPERIMENTAL
Intervention: Female condoms
Number of subjects: 0
Study 15923284 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm
Number of subjects: 0
Study 15923284 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbicide products
Number of subjects: 0
Study 12224369 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium acetate gelcaps
Number of subjects: 22
Study 12224369 — intervention group
Group type: COMPARATOR
Intervention: Calcium acetate tablets
Number of subjects: 22
Study 9685102 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit weight training (CWT) protocols at 40% and 60% of one-repetition maximum (1-RM) with 30 or 60 seconds of rest between exercises.
Number of subjects: 0
Study 9685102 — intervention group
Group type: EXPERIMENTAL
Intervention: CWT protocols (60% of 1-RM)
Number of subjects: 0
Study 9685102 — intervention group
Group type: COMPARATOR
Intervention: Maximal treadmill test
Number of subjects: 0
Study 8117174 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 0
Study 8117174 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction
Number of subjects: 0
Study 8117174 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial infarction during follow-up
Number of subjects: 0
Study 8117174 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 0
Study 8117174 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 0
Study 8117174 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline left ventricular dysfunction
Number of subjects: 0
Study 2809914 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% intralipid
Number of subjects: 28
Study 2809914 — intervention group
Group type: COMPARATOR
Intervention: 20% intralipid
Number of subjects: 28
Study 31419490 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug provocation testing (DPT) to amoxicillin over 3 days
Number of subjects: 71
Study 31419490 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin allergy evaluation with DPT
Number of subjects: 71
Study 27660995 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive psychotherapy (IP; n = 163)
Number of subjects: 243
Study 27660995 — intervention group
Group type: COMPARATOR
Intervention: Collaborative care (CC; n = 130)
Number of subjects: 243
Study 27660995 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive psychotherapy (IP)
Number of subjects: 243
Study 27660995 — intervention group
Group type: COMPARATOR
Intervention: Collaborative care (CC)
Number of subjects: 243
Study 25516195 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose simvastatin (80 mg daily for 3 weeks)
Number of subjects: 0
Study 25516195 — intervention group
Group type: COMPARATOR
Intervention: Low-dose simvastatin (40 mg daily for 3 weeks)
Number of subjects: 0
Study 23321148 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered implants (n=51)
Number of subjects: 105
Study 23321148 — intervention group
Group type: COMPARATOR
Intervention: Uncovered implants (n=54)
Number of subjects: 105
Study 21346609 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 40